BioMarin Pharmaceutical Inc. announced that the Board of Directors has appointed Ian T. Clark as Chair of the Board, subject to his election at the company's Annual Meeting of Stockholders on June 2, 2026. Mr. Clark will succeed Richard A. Meier, who is retiring after two decades on the Board, and the appointment will become effective immediately following the Annual Meeting. Mr. Meier joined BioMarin's Board in 2006, playing a key role in the company's evolution.
He was Lead Independent Director before being elected Chair in 2023. During this period, profitability improved meaningfully, with significant expansion in non-GAAP operating margin, earnings-per-share growth and substantial cash flow generation.
